Shared on 04 Sep 25
AI Adoption And FedRAMP Certification Will Widen Market Opportunities
Despite an unchanged analyst price target for Docebo, the sharp rise in its future P/E ratio suggests heightened growth expectations are being offset by valuation concerns, resulting in no adjustment to its fair value at CA$55.02. What's in the News Docebo provided earnings guidance for Q3 2025, expecting total revenue between $61.0 million and $61.2 million.
Shared on 01 May 25
Fair value Decreased 18%AI Adoption And FedRAMP Certification Will Widen Market Opportunities
Shared on 23 Apr 25
Fair value Decreased 1.67%FedRAMP Status And Deloitte Partnership Will Open New Markets And Expand Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 2.98%FedRAMP Status And Deloitte Partnership Will Open New Markets And Expand Opportunities
AnalystConsensusTarget has decreased revenue growth from 11.9% to 10.6%.
Shared on 09 Apr 25
Fair value Decreased 1.90%FedRAMP Status And Deloitte Partnership Will Open New Markets And Expand Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 3.86%FedRAMP Status And Deloitte Partnership Will Open New Markets And Expand Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 2.87%FedRAMP Status And Deloitte Partnership Will Open New Markets And Expand Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 34%FedRAMP Status And Deloitte Partnership Will Open New Markets And Expand Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 13 Mar 25

